The Efficacy of Bisphosphonates in Preventing Aromatase Inhibitor Induced Bone Loss for Postmenopausal Women with Early Breast Cancer: A Systematic Review and Meta-Analysis
Figure 4
(a) Forest plot from meta-analysis of the BMD change of patients on aromatase inhibitors treated with bisphosphonates (ibandronate/risedronate) compared with aromatase inhibitors alone in osteopenic patients. (b) Funnel plot from meta-analysis of the BMD change of patients on aromatase inhibitors treated with bisphosphonates (ibandronate/risedronate) compared with aromatase inhibitors alone in osteopenic patients.
